MarginsXMarginsX
Home › Markets › Health Care › TMDX

TransMedics Group Inc. (TMDX)

TMDX trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$92.21
+0.91% on the day
Market cap
$3.2B
Mid cap
Revenue · 2025
$605.5M
+37.1% on 2024
Net income · 2025
$190.3M
31.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1756262/000119312526067032/0001193125-26-067032-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerTMDX on Nasdaq
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryUnited States
IPO year2019
SEC CIK0001756262
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Incorporated inMA

Financials · 2025

LineValue
Revenue$605.5M
Net income$190.3M
Operating income$108.6M
Net margin31.4%
Operating margin17.9%
Revenue growth+37.1%
Cash$488.9M
Total assets$1.1B
P/E (computed)16.8×
P/S (computed)5.3×

Warning signs

Cash runway
Cash-flow positive
$511.4M cash at September 30, 2026
Share count, 1 year
+1.6%
2025-10-17 to 2026-11-02 · +6.4% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
-$3.8M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$511.4M cash; operating cash flow $28.1M a quarter.Report 2026-09-30
Shares outstanding34,733,883 (2026-11-02); 34,174,325 a year earlier; 32,647,698 three years earlier.Cover page 2026-11-02
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Boston, Massachusetts, United StatesPCAOB Form AP 2026-03-17
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $1.1M, sold $4.9M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$203.0M$17.1M$36.0M$511.4M$54.8M$727.6M10-Q 2026-11-05
Q2 2026
2026-06-30
$189.9M$14.7M$17.3M$491.1M$59.7M$668.5M10-Q 2026-08-04
Q1 2026
2026-03-31
$173.9M$7.3M$24.5M$480.2M$59.7M$635.9M10-Q 2026-05-05
Q4 2025
2025-12-31
$160.8M$105.4M$34.5M$488.9M$59.6M$605.5M10-K 2026-02-24
Q3 2025
2025-09-30
$143.8M$24.3M$69.6M$466.7M$59.6M$566.4M10-Q 2026-11-05
Q2 2025
2025-06-30
$157.4M$34.9M$91.6M$401.1M$59.5M$531.3M10-Q 2026-08-04
Q1 2025
2025-03-31
$143.5M$25.7M-$2.9M$310.6M$59.4M$488.2M10-Q 2026-05-05
Q4 2024
2024-12-31
$121.6M$6.9M$19.7M$337.1M$59.4M$441.5M10-K 2026-02-24

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52022-08-05
Latest annual report10-K2026-02-24
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-05
Latest proxyDEFA14A2026-05-07

Source: SEC EDGAR submissions feed, 632 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+3.6%
1 month+15.5%
3 months+1.9%
Year to date-24.9%
1 year-20.9%
From 52-week high-39.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
AXGNAxogen Inc.$55.38-0.98%$3.3B
LIVNLivaNova PLC$92.44+1.23%$5.1B
CNMDCONMED Corporation$49.35-2.45%$1.5B
CBLLCeriBell Inc.$26.42+1.07%$1.0B
INMDInMode Ltd.$13.15-0.90%$755.9M
CVCapsoVision Inc.$6.47+7.30%$346.9M
ELMDElectromed Inc.$23.10-5.02%$188.8M
FOCLEDAP TMS S.A.$3.17-2.39%$149.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier